Alx Oncology Holdings (ALXO) Tax Provisions (2019 - 2020)
Alx Oncology Holdings (ALXO) posted Tax Provisions of $182000.0 for Q4 2020, up 420.0% sequentially from $35000.0 in Q3 2020, and up 1922.22% YoY from $9000.0 in Q1 2020.
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Tax Provisions (2019 - 2020) Analysis & Trends
Alx Oncology Holdings has reported Tax Provisions for 2 years, with the latest figure at $182000.0 in Q4 2020.
- Quarterly Tax Provisions rose 1922.22% year-over-year to $182000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $241000.0 (changed N/A YoY) and the FY2024 annual result came in at -$28.3 million, changed N/A from the prior year.
- Tax Provisions advanced to $182000.0 in Q4 2020 per ALXO's latest filing, from $35000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $182000.0 in Q4 2020 and troughed at $4000.0 in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Alx Oncology Holdings | 274.67 Mn | 274.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -9.61 Mn |
| Sep 30, 2020 | 35,000.00 |
| Jun 30, 2020 | 20,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | -4.06 Mn |
| Sep 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 8,000.00 |